Results 141 to 150 of about 131,312 (209)

Directional cues from CXCR4 [PDF]

Nature Reviews Immunology, 2003
openaire   +1 more source

Gene therapy via CRISPR/Cas9-mediated Cxcr4 disease allele inactivation reverses leukopenia in WHIM mice. [PDF]

J Clin Invest
Gao JL, Li Z, Calderon-Perez R, Pavek A, Kim L, McDermott DH, Murphy PM.   +6 more
europepmc   +1 more source

Decreased potential for lymphatic vessel generation is a hallmark of early diagnosed arterial hypertension and can be reversed by treatment with angiotensin converting enzyme inhibitors. [PDF]

Sci Rep
Gliwiński M, Koliński T, Urban-Wójciuk Z, Zieliński M, Piekarska K, Fraściszewska M, Żyłko A, Pęksa R, Karczewska J, Peszyńska-Sularz G, Trzeciak B, Molisz A, Gutknecht P, Reiwer-Gostomska M, Pietrzykowska M, Iwaszkiewicz-Grześ D, Biernat W, Glasner P, Glasner L, Chruściel E, Trzonkowski P, Siebert J, Marek-Trzonkowska NM.   +22 more
europepmc   +1 more source

Based on single-cell and transcriptome analysis of inflammatory pathway biomarkers and their molecular mechanisms in chronic obstructive pulmonary disease. [PDF]

PLoS One
Zhou Y, Gong H, Hao Z, Wang L, Li L, Zou X.   +5 more
europepmc   +1 more source

CXCR4 Inhibitor Q-122 [PDF]

, 2020
openaire   +1 more source

The Role of 68Ga-Pentixafor and 18F-Fluorodeoxyglucose (18F-FDG) PET/CT in a Case of Multiple Myeloma. [PDF]

Cureus
Kumar A, Chaudhuri T, Pradhan M, Singh P, Gupta B.   +4 more
europepmc   +1 more source

Engineered mesenchymal stem cells expressing CXCR4 and LIGHT enhance Anti-Tumor activity in a subcutaneous gastric cancer xenograft model. [PDF]

Med Oncol
Anayyat U, Ye J, Wu X, Liu Z, Liao C, Wang X, Liu M.   +6 more
europepmc   +1 more source

CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting. [PDF]

Nat Commun
Itoh-Nakadai A, Liang M, Shindo M, Bibi C, Tomizawa-Murasawa M, Fujiki S, Kaneko A, Kanamaru E, Hashimoto M, Kajita H, Ando Y, Kojima M, Moody J, Iwasaki M, Takagi S, Nakagawa R, Agrawal S, Amitani-Iijima H, Sato K, Sorimachi Y, Suzuki N, Fukami T, Hanada K, Morita S, Katsura K, Matsumoto T, Kobayashi M, Kato M, Negishi Y, Shirouzu M, Najima Y, Takubo K, Hon CC, Uchida N, Taniguchi S, Momozawa Y, Carninci P, Shultz LD, Saito Y, de Hoon M, Shin JW, Ishikawa F.   +41 more
europepmc   +1 more source

CXCR4 Antagonist BL-8040 [PDF]

, 2020
openaire   +1 more source